Mylan Dublin is an API and finished-dose manufacturer based in Ireland. It holds 2 active US drug master files across a filed portfolio of 2 molecules. Its filings concentrate with US FDA, JFDA (JO) and MCAZ (ZW). Its GMP standing is certified by CDSCO (India) and MHRA (UK).
| Site | FDA FEI |
|---|---|
| Bangalore- 562105, United Arab Emirates | Not on file |
| Bangalore 562105, United Arab Emirates | Not on file |
| DUBLIN, Ireland | Not on file |
| BANGALORE, India | Not on file |
| hosur 635 130, India | Not on file |
| Hosur –, India | Not on file |
6 further sites are on record.
| Molecule | Regulators | Docs |
|---|---|---|
| Fomepizole | US FDA | 1 |
| Isosulfan Blue | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | 546 | None |
| JFDA (JO) | 9 | None |
| MCAZ (ZW) | 2 | None |
| EDE (AE) | 1 | None |
| CDSCO (India) | None | 10 |
| MHRA (UK) | None | 2 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Mylan Dublin comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.